Morepen Laboratories Secures Rs 30 Crore Unsecured Term Loan Facility from Shinhan Bank
Morepen Laboratories Limited announced on April 23, 2026, that its Finance Committee approved the availing of an unsecured term loan facility from Shinhan Bank. The facility amounts to a total of Rs. 30,00,00,000/- (Rupees Thirty Crore Only).The loan agreement is designed to secure credit facilities for the company's general business purposes. Mr. Sushil Suri, Promoter, Chairman & Managing Director, has extended a personal guarantee to Shinhan Bank against this term loan facility.
The core details of the secured loan facility are as follows:
| Detail | Description |
|---|---|
| Lender | Shinhan Bank |
| Borrower | Morepen Laboratories Limited |
| Loan Amount | Rs. 30,00,00,000/- (Rupees Thirty Crore Only) |
| Interest Rate | 7.60% (Calculated as Repo rate of 5.25% plus a spread of 2.35%, as on date) |
| Tenure | 36 months |
| Repayment Terms | 10 equal quarterly instalments, with a 6-month moratorium period |
| Security | Personal guarantee provided by Mr. Sushil Suri |
In addition to the new facility, the company reported that its total outstanding loan exposure, excluding the current facility, stands at Rs. 182.62 Crore*. Of the loan dues previously outstanding with Shinhan Bank (excluding the present facility), an amount of Rs. 20.45 crore is currently outstanding.
The agreement, executed on April 23, 2026, is confirmed to be a transaction not considered a related party transaction.
MOREPENLAB Stock Price Movement
Today, Morepen Laboratories Limited shares slipped by 0.63% to settle at ₹42.69. Trading activity saw a total volume of 5.12 million shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.